Global Opioid Induced Constipation (OIC) Drug Market Insights, Forecast to 2025

Global Opioid Induced Constipation (OIC) Drug Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Opioid Induced Constipation (OIC) Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Product
1.4.2 Lubiprostone
1.4.3 Methyl Naltrexone Bromide
1.4.4 Naldemedine
1.4.5 Alvimopan
1.4.6 Other
1.5 Market by End User
1.5.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Opioid Induced Constipation (OIC) Drug Market Size
2.1.1 Global Opioid Induced Constipation (OIC) Drug Revenue 2014-2025
2.1.2 Global Opioid Induced Constipation (OIC) Drug Sales 2014-2025
2.2 Opioid Induced Constipation (OIC) Drug Growth Rate by Regions
2.2.1 Global Opioid Induced Constipation (OIC) Drug Sales by Regions
2.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
3.1.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
3.1.2 Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers
3.1.3 Global Opioid Induced Constipation (OIC) Drug Market Concentration Ratio (CR5 and HHI)
3.2 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers
3.2.1 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2014-2019)
3.2.2 Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2014-2019)
3.3 Opioid Induced Constipation (OIC) Drug Price by Manufacturers
3.4 Opioid Induced Constipation (OIC) Drug Manufacturing Base Distribution, Product Types
3.4.1 Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioid Induced Constipation (OIC) Drug Product Type
3.4.3 Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Opioid Induced Constipation (OIC) Drug Sales by Product
4.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Product
4.3 Opioid Induced Constipation (OIC) Drug Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Opioid Induced Constipation (OIC) Drug Breakdown Data by End User
6 North America
6.1 North America Opioid Induced Constipation (OIC) Drug by Countries
6.1.1 North America Opioid Induced Constipation (OIC) Drug Sales by Countries
6.1.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Opioid Induced Constipation (OIC) Drug by Product
6.3 North America Opioid Induced Constipation (OIC) Drug by End User
7 Europe
7.1 Europe Opioid Induced Constipation (OIC) Drug by Countries
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Countries
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Opioid Induced Constipation (OIC) Drug by Product
7.3 Europe Opioid Induced Constipation (OIC) Drug by End User
8 Asia Pacific
8.1 Asia Pacific Opioid Induced Constipation (OIC) Drug by Countries
8.1.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Countries
8.1.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Opioid Induced Constipation (OIC) Drug by Product
8.3 Asia Pacific Opioid Induced Constipation (OIC) Drug by End User
9 Central & South America
9.1 Central & South America Opioid Induced Constipation (OIC) Drug by Countries
9.1.1 Central & South America Opioid Induced Constipation (OIC) Drug Sales by Countries
9.1.2 Central & South America Opioid Induced Constipation (OIC) Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Opioid Induced Constipation (OIC) Drug by Product
9.3 Central & South America Opioid Induced Constipation (OIC) Drug by End User
10 Middle East and Africa
10.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Countries
10.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Countries
10.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Product
10.3 Middle East and Africa Opioid Induced Constipation (OIC) Drug by End User
11 Company Profiles
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
11.1.5 Ironwood Pharmaceuticals Recent Development
11.2 Daiichi Sankyo Co
11.2.1 Daiichi Sankyo Co Company Details
11.2.2 Company Business Overview
11.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Products Offered
11.2.5 Daiichi Sankyo Co Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Products Offered
11.3.5 Pfizer Recent Development
11.4 Progenics Pharmaceuticals
11.4.1 Progenics Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
11.4.5 Progenics Pharmaceuticals Recent Development
11.5 Shionogi &
11.5.1 Shionogi & Company Details
11.5.2 Company Business Overview
11.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Products Offered
11.5.5 Shionogi & Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Company Business Overview
11.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Allergan Opioid Induced Constipation (OIC) Drug Products Offered
11.6.5 Allergan Recent Development
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Details
11.7.2 Company Business Overview
11.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Products Offered
11.7.5 Nektar Therapeutics Recent Development
11.8 Purdue Pharma
11.8.1 Purdue Pharma Company Details
11.8.2 Company Business Overview
11.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Products Offered
11.8.5 Purdue Pharma Recent Development
11.9 S.L.A. Pharma
11.9.1 S.L.A. Pharma Company Details
11.9.2 Company Business Overview
11.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Products Offered
11.9.5 S.L.A. Pharma Recent Development
11.10 Mundipharma International Limited
11.10.1 Mundipharma International Limited Company Details
11.10.2 Company Business Overview
11.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Products Offered
11.10.5 Mundipharma International Limited Recent Development
11.11 Ono Pharmaceutical
11.12 Takeda Pharmaceutical Company Limited
11.13 Theravance Biopharma
11.14 Valeant Pharmaceuticals International
11.15 Cosmo Pharmaceuticals SA
11.16 Daewoong Pharmaceutical
11.17 C.B. Fleet Company
11.18 Sucampo Pharmaceuticals
12 Future Forecast
12.1 Opioid Induced Constipation (OIC) Drug Market Forecast by Regions
12.1.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions 2019-2025
12.2 Opioid Induced Constipation (OIC) Drug Market Forecast by Product
12.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Product 2019-2025
12.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Product 2019-2025
12.3 Opioid Induced Constipation (OIC) Drug Market Forecast by End User
12.4 North America Opioid Induced Constipation (OIC) Drug Forecast
12.5 Europe Opioid Induced Constipation (OIC) Drug Forecast
12.6 Asia Pacific Opioid Induced Constipation (OIC) Drug Forecast
12.7 Central & South America Opioid Induced Constipation (OIC) Drug Forecast
12.8 Middle East and Africa Opioid Induced Constipation (OIC) Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Opioid Induced Constipation (OIC) Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Opioid Induced Constipation (OIC) Drug Product Picture
Table Opioid Induced Constipation (OIC) Drug Market Segments
Table Key Manufacturers Opioid Induced Constipation (OIC) Drug Covered
Table Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Product 2014-2025
Figure Lubiprostone Product Picture
Table Major Manufacturers of Lubiprostone
Figure Methyl Naltrexone Bromide Product Picture
Table Major Manufacturers of Methyl Naltrexone Bromide
Figure Naldemedine Product Picture
Table Major Manufacturers of Naldemedine
Figure Alvimopan Product Picture
Table Major Manufacturers of Alvimopan
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Figure Opioid Induced Constipation (OIC) Drug Report Years Considered
Figure Global Opioid Induced Constipation (OIC) Drug Market Size 2014-2025 (Million US$)
Figure Global Opioid Induced Constipation (OIC) Drug Sales 2014-2025 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Sales by Regions 2014-2019 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions 2014-2019
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions
Table Global Opioid Induced Constipation (OIC) Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions 2014-2019
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions
Table Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2014-2019) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2014-2019)
Figure Opioid Induced Constipation (OIC) Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Opioid Induced Constipation (OIC) Drug Price (2014-2019) (USD/Unit)
Table Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Opioid Induced Constipation (OIC) Drug Product Type
Table Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Opioid Induced Constipation (OIC) Drug Sales by Product (2014-2019) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Product (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Product (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Product in 2018
Table Global Opioid Induced Constipation (OIC) Drug Revenue by Product (2014-2019) (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Share by Product (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Product (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Product in 2018
Table Opioid Induced Constipation (OIC) Drug Price by Product 2014-2019 (USD/Unit)
Table Global Opioid Induced Constipation (OIC) Drug Sales by End User (2014-2019) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by End User (2014-2019)
Figure Global Sales Opioid Induced Constipation (OIC) Drug Market Share by End User (2014-2019)
Figure Global Sales Opioid Induced Constipation (OIC) Drug Market Share by End User in 2018
Figure North America Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure North America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Opioid Induced Constipation (OIC) Drug Sales by Countries (2014-2019) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table North America Opioid Induced Constipation (OIC) Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure United States Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure United States Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Canada Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Opioid Induced Constipation (OIC) Drug Sales by Product (2014-2019) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Opioid Induced Constipation (OIC) Drug Market Share by Product
Table North America Opioid Induced Constipation (OIC) Drug Sales by End User (2014-2019) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Opioid Induced Constipation (OIC) Drug Market Share by End User
Figure Europe Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure Europe Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Opioid Induced Constipation (OIC) Drug Sales by Countries (2014-2019) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Europe Opioid Induced Constipation (OIC) Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure Germany Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Germany Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure France Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure UK Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Italy Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Russia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Opioid Induced Constipation (OIC) Drug Sales by Product (2014-2019) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Opioid Induced Constipation (OIC) Drug Market Share by Product
Table Europe Opioid Induced Constipation (OIC) Drug Sales by End User (2014-2019) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Opioid Induced Constipation (OIC) Drug Market Share by End User
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure China Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure China Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Japan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Korea Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure India Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Australia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Product (2014-2019) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Share by Product
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by End User (2014-2019) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Share by End User
Figure Central & South America Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by Countries (2014-2019) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Central & South America Opioid Induced Constipation (OIC) Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure Brazil Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by Product (2014-2019) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Opioid Induced Constipation (OIC) Drug Market Share by Product
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by End User (2014-2019) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Opioid Induced Constipation (OIC) Drug Market Share by End User
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure GCC Countries Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Share by Product
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Share by End User
Table Ironwood Pharmaceuticals Company Details
Table Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ironwood Pharmaceuticals Recent Development
Table Daiichi Sankyo Co Company Details
Table Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Daiichi Sankyo Co Recent Development
Table Pfizer Company Details
Table Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Progenics Pharmaceuticals Company Details
Table Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Progenics Pharmaceuticals Recent Development
Table Shionogi & Company Details
Table Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shionogi & Recent Development
Table Allergan Company Details
Table Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Recent Development
Table Nektar Therapeutics Company Details
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nektar Therapeutics Recent Development
Table Purdue Pharma Company Details
Table Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Purdue Pharma Recent Development
Table S.L.A. Pharma Company Details
Table S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table S.L.A. Pharma Recent Development
Table Mundipharma International Limited Company Details
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mundipharma International Limited Recent Development
Table Ono Pharmaceutical Company Details
Table Takeda Pharmaceutical Company Limited Company Details
Table Theravance Biopharma Company Details
Table Valeant Pharmaceuticals International Company Details
Table Cosmo Pharmaceuticals SA Company Details
Table Daewoong Pharmaceutical Company Details
Table C.B. Fleet Company Company Details
Table Sucampo Pharmaceuticals Company Details
Table Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions 2019-2025 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Product 2019-2025 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Product 2019-2025
Table Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Opioid Induced Constipation (OIC) Drug Sales Forecast by End User 2019-2025 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Opioid Induced Constipation (OIC) Drug Value Chain
Table Opioid Induced Constipation (OIC) Drug Customers List
Table Opioid Induced Constipation (OIC) Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs